California device startup and women’s health firmMinerva Surgical has recently raised $20 million, according to a regulatory filing.
The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treatheavy menstrual bleeding.
Based on a search of the U.S. Securities and Exchange Commission’s Edgar database, the company has been steadily raising money since 2008 and has raised more than $55 million. David M. Clapper, a 16-year veteran of Johnson & Johnson, is Minerva Surgical’s CEO.
Venture capital firm New Enterprise Associates and Vivo Ventures are investors in the company, although it is not known whether they invested in this round of funding.
[Photo Credit: Pile of Money from Big Stock Photo]
By Arundhati Parmar
Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.More posts by Author
Based upon a bing search of the U.S. Securities and Exchange Commission’s Edgar database, the business happens to be steadily raising funds since 2008 and also brought up over $55 billion. David M. Clapper, a 16-year seasoned of Johnson & Johnson, is Minerva Surgical’s CEO